S'abonner

Multinational consensus antimicrobial stewardship recommendations for children managed in hospital settings - 25/05/23

Doi : 10.1016/S1473-3099(22)00726-5 
Brendan McMullan, PhD a, b, c, , Penelope A Bryant, PhD d, e, f, g, Eamon Duffy, BPharm h, i, j, Julia Bielicki, PhD k, l, Pieter De Cock, ProfPhD m, n, o, Michelle Science, MD p, q, Tracy Zembles, PharmD r, Kathryn Timberlake, PharmD s, Elizabeth Monsees, PhD t, u, Rana F Hamdy, MD v, w, Alison C Tribble, MD x, Jason Newland, ProfMD y, Sanjay Patel, MBBS z
a Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia 
b Department of Immunology, Sydney Children’s Hospital Randwick, Sydney, NSW, Australia 
c Department of Infectious Diseases, Sydney Children’s Hospital Randwick, Sydney, NSW, Australia 
d Departments of Hospital-in-the-Home, The Royal Children’s Hospital, Melbourne, VIC, Australia 
e Department of Infectious Diseases, The Royal Children’s Hospital, Melbourne, VIC, Australia 
f Murdoch Children’s Research Institute, Melbourne, VIC, Australia 
g Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia 
h Departments of Infectious Disease, Te Whatu Ora Health New Zealand, Auckland, New Zealand 
i Department of Pharmacy, Te Whatu Ora Health New Zealand, Auckland, New Zealand 
j Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand 
k Department of Paediatric Infectious Diseases and Infection Prevention and Control, University of Basel Children’s Hospital, Basel, Switzerland 
l Centre for Neonatal and Paediatric Infection, St George’s University, London, UK 
m Department of Pharmacy, Ghent University Hospital, Ghent, Belgium 
n Department of Pediatric Intensive Care, Ghent University Hospital, Ghent, Belgium 
o Department of Basic and Applied Medical Sciences, Ghent University, Ghent, Belgium 
p Division of Infectious Diseases, The Hospital for Sick Children, Toronto, ON, Canada 
q Department of Paediatrics, University of Toronto, Toronto, ON, Canada 
r Department of Enterprise Safety, Children’s Wisconsin, WI, Milwaukee, USA 
s Department of Pharmacy, The Hospital for Sick Children, Toronto, ON, Canada 
t Children’s Mercy Hospital, Kansas City, MO, USA 
u Department of Pediatrics, University of Missouri-Kansas City, Kansas City, MO, USA 
v Division of Infectious Diseases, Children’s National Hospital, Washington DC, USA 
w Department of Pediatrics, George Washington School of Medicine and Health Sciences, Washington DC, USA 
x Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA 
y Department of Infectious Diseases, Washington University School of Medicine in St Louis, St Louis, MO, USA 
z Department of Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital, Southampton, UK 

* Correspondence to: Dr Brendan McMullan, Department of Immunology and Infectious Diseases, Sydney Children’s Hospital, Randwick, NSW 2031, Australia Department of Immunology and Infectious Diseases Sydney Children’s Hospital Randwick NSW 2031 Australia

Summary

Children are entitled to receive antibiotic therapy that is based on evidence and best practice, but might be overlooked in hospital programmes designed to achieve antimicrobial stewardship [AMS]. This failure to include children could be because children make up small proportion of patients in most hospitals, and are cared for by specialised paediatric staff. We reviewed the evidence and consulted experts in three global regions to develop ten recommendations for good-practice in hospital AMS programmes for children. We performed a review of scientific research, published between Jan 1, 2007, and Oct 17, 2019, concerning AMS, and formed a multinational expert group comprising members from the USA, Canada, the UK, Belgium, Switzerland, Australia, and Aotearoa New Zealand to develop the recommendations. These recommendations aim to help health-care workers who care for children in these regions to deliver best-practice care. We surveyed health-care workers with expertise in antibiotic therapy for children across these regions, and found that the recommendations were considered both very important and generally feasible. These recommendations should be implemented in hospitals to improve antibiotic therapy for children and to stimulate research into future improvements in care.

Le texte complet de cet article est disponible en PDF.

Plan


© 2023  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 23 - N° 6

P. e199-e207 - juin 2023 Retour au numéro
Article précédent Article précédent
  • Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
  • Martin Hoenigl, Jon Salmanton-García, Matthias Egger, Jean-Pierre Gangneux, Tihana Bicanic, Sevtap Arikan-Akdagli, Ana Alastruey-Izquierdo, Nikolai Klimko, Aleksandra Barac, Volkan Özenci, Eelco F J Meijer, Nina Khanna, Matteo Bassetti, Riina Rautemaa-Richardson, Katrien Lagrou, Kai-Manuel Adam, Emin Halis Akalin, Murat Akova, Valentina Arsic Arsenijevic, Avinash Aujayeb, Ola Blennow, Stéphane Bretagne, François Danion, Blandine Denis, Nick Alexander de Jonge, Guillaume Desoubeaux, Lubos Drgona, Nurettin Erben, Andrea Gori, Julio García Rodríguez, Carolina Garcia-Vidal, Daniele Roberto Giacobbe, Anna L Goodman, Petr Hamal, Helena Hammarström, Cristina Toscano, Fanny Lanternier, Cornelia Lass-Flörl, Deborah E A Lockhart, Thomas Longval, Laura Loughlin, Tadeja Matos, Malgorzata Mikulska, Manjusha Narayanan, Sonia Martín-Pérez, Juergen Prattes, Benedict Rogers, Laman Rahimli, Maite Ruiz, Emmanuel Roilides, Michael Samarkos, Ulrike Scharmann, Uluhan Sili, Oguz Resat Sipahi, Alena Sivakova, Joerg Steinmann, Janina Trauth, Ozge Turhan, Jens Van Praet, Antonio Vena, P Lewis White, Birgit Willinger, Anna Maria Tortorano, Maiken C Arendrup, Philipp Koehler, Oliver A Cornely, ECMM Candida III Study Group, Mario Tumbarello, Alida Fe Talento, Alba C Ruiz, Zdenek Racil, Igor Stoma, Maria Calbacho, Eric Van Wijngaerden, Júlia Henriques, Harriett Jordan, Valentina Ferroni, Ozlem Koyuncu Ozyurt, Christopher Milacek, Robert Krause, Christoph Zurl, Matthijs Backx, Ang Li, Raphael Seufert, Rok Tomazin, Yael Blankenheim, Julio Dávila-Valls, Paloma García-Clemente, Tomas Freiberger, Jochem Buil, Jacques F Meis, Deniz Akyol, Hélène Guegan, Clare Logan
| Article suivant Article suivant
  • The wrongful indictment of pre-referral rectal artesunate further delays the roll-out of this lifesaving drug
  • Lorenz von Seidlein

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.